Our assets are yours


With the experienced ATLANSTAT employees, our customers entrust us to perform independent statistical analysis.
We can independently manage interim statistical analysis and conduct Data Monitoring Committees directly with experts without needing to notify the sponsor of the results.


As well as experience with the private sector, ATLANSTAT also understand working with institutions: CHUs, UNICANCER, INSERM ...

ATLANSTAT implements its services in compliance with current EMA (European Medicines Agency) and FDA (Food and Drug Administration) regulations and recommendations and actively participates in submitting health products internationally.


ATLANSTAT has developed partnerships with government agencies to offer innovative statistical offers.

It was accompanied by BPI France in a project to develop a randomization tool for adaptive trials.

In partnership with the University Hospital of Nantes and INSERM ATLANSTAT is developing an innovative statistical methodology to accurately identify a population of patients unresponsive to treatment where the criterion to identify this population has not yet been measured ... It is a project that is part of the development of personalized medicine.

Contact us for more information!


ATLANSTAT is a member of Atlanpole Biotherapies cluster. This cluster brings together the skills of laboratories, companies and platforms for comprehensive private-public offer on the bio-drug value chain from target discovery to clinical evaluation.

ATLANSTAT joined the UN Global Compact initiative guaranteeing its commitment in Corporate Social Responsibility policy (CSR).

ATLANSTAT is a member of the French Association of CROs (AFCROs).